Comparar métodos

	QLQ-LC13 de la EORTC: Calidad de Vida en Cáncer de Pulmón	EORTC QLQ-C15-PAL: Calidad de Vida en Cuidados Paliativos Oncológicos
Campo	Oncología	Oncología
Familia	Process / pipeline	Process / pipeline
Año de origen	1994	2006
Autor original	Bergman, B., et al. (EORTC Quality of Life Group)	Groenvold, M., et al. (EORTC Quality of Life Group)
Tipo	Self-report questionnaire	Self-report questionnaire
Fuente seminal	Bergman, B., Aaronson, N. K., Ahmedzai, S., Kaasa, S., & Sullivan, M. (1994). The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer, 30A(5), 635–642.	Groenvold, M., Petersen, M. A., Aaronson, N. K., Arraras, J. I., Blazeby, J. M., Bottomley, A., et al. (2006). The development of the EORTC QLQ-C15-PAL: a shortened quality-of-life questionnaire for cancer patients in palliative care. Eur J Cancer, 42(1), 55–64.
Alias	QLQ-LC13	QLQ-C15-PAL
Relacionados	5	5
Resumen	The EORTC QLQ-LC13 is a 13-item lung-cancer-specific module designed to complement the 30-item EORTC QLQ-C30 core questionnaire. Developed and validated by Bergman et al. in 1994, it measures lung-specific symptoms (dyspnea, cough, hemoptysis, chest pain) and treatment toxicities (sore mouth, dysphagia). It is the standard lung cancer-specific QoL instrument in European and international trials.	The EORTC QLQ-C15-PAL is a 15-item quality-of-life instrument specifically designed for advanced cancer patients receiving palliative care. Developed by Groenvold et al. in 2006, it is a shortened version of the QLQ-C30, retaining core QoL domains while reducing respondent burden—critical in palliative settings where fatigue and functional impairment limit questionnaire completion. It measures physical, emotional, and functional well-being alongside key palliative symptoms.